Updates in Juvenile Localized Scleroderma

Explore a comprehensive lecture on localized scleroderma, also known as morphea, focusing on its impact on children and adults. Learn about the different manifestations of this skin and underlying tissue condition across age groups. Discover the appropriate evaluation methods for various types of localized scleroderma and gain insights into treatment options and expected outcomes. Delve into topics such as the normal healing process disruption, inflammation and fibrosis, skin patterns, and the challenges associated with the condition. Understand the differences between topical and systemic treatments, with a focus on methotrexate. Examine the effects of puberty, muscle atrophy, and European consensus recommendations. Gain knowledge about long-term prognosis, ongoing research efforts, and ways parents can support affected children. This 50-minute presentation, part of the 2022 Kids Get Scleroderma Too! Education Conference, provides valuable information for patients, families, and healthcare professionals dealing with juvenile localized scleroderma.

Introduction
Overview
Localized Scleroderma vs systemic sclerosis
Normal healing process disrupted
Inflammation and fibrosis
Skin patterns
Problems
Treatment
Topical vs systemic
Methotrexate
When can we expect improvement
How long do we treat
Effects of puberty
Other options
Muscle atrophy
European consensus recommendations
Longterm prognosis
Research efforts
Questions to answer
Research
Thank you
Any questions
How can parents help
Outro